Why it matters
The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
Project record
At a glance
- Company
- Eli Lilly
- Industry
- Pharmaceuticals
- Location
- Concord, North Carolina
- Investment
- $1.00B
- Permanent jobs announced
- 600
- Status
- Operational
- Announced
- Mar 29, 2022
- Operations began
- Jun 1, 2024
- Added to tracker
- Apr 15, 2025
Sources
Official references
- Primary source https://investor.lilly.com/news-releases/news-release-details/lilly-announces-1-billion-investment-new-manufacturing-facility
Related
Other projects to know
In North Carolina
- PharmaceuticalsJohnson & JohnsonWilson, North Carolina$2.00B500 jobs
- PharmaceuticalsAmgen (Holly Springs Expansion)Holly Springs, North Carolina$1.00B370 jobs
- PharmaceuticalsNovo NordiskClayton, North Carolina$4.10B1,000 jobs
- PharmaceuticalsAmgen (Holly Springs)Holly Springs, North Carolina$550.0M355 jobs
Back to the tracker/projects/eli-lilly-concord